Buprenorphine May Boost HIV Treatment

被引：0
|
作者：
Kuehn, Bridget M.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 304卷 / 03期
关键词：
D O I：
10.1001/jama.2010.963
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：261 / 263
页数：3
相关论文
共 50 条
  • [31] RETENTION IN BUPRENORPHINE MAINTENANCE TREATMENT IS ASSOCIATED WITH LOWER RISK OF INCARCERATION AMONG HIV PATIENTS
    Fox, Aaron D.
    Riggins, Daniel P.
    Ning, Yuming
    Cunningham, Chinazo
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S389 - S390
  • [32] The BHIVES Collaborative: Organization and Evaluation of a Multisite Demonstration of Integrated Buprenorphine/Naloxone and HIV Treatment
    Weiss, Linda
    Egan, James E.
    Botsko, Michael
    Netherland, Julie
    Fiellin, David A.
    Finkelstein, Ruth
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 : S7 - S13
  • [33] Buprenorphine treatment: An update
    Vigezzi, P
    Guglielmino, L
    Silenzio, R
    De Chiara, M
    Corrado, F
    Marzorati, P
    Cocchi, L
    Cozzolino, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S348 - S348
  • [34] A Model Federal Collaborative to Increase Patient Access to Buprenorphine Treatment in HIV Primary Care
    Cheever, Laura W.
    Kresina, Thomas F.
    Cajina, Adan
    Lubran, Robert
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 : S3 - S6
  • [35] BRIEF VERSUS EXTENDED COUNSELING FOR HIV CLINIC BASED BUPRENORPHINE TREATMENT OF OPIOID DEPENDENCE
    Tetrault, Jeanette
    Moore, Brent
    Barry, Declan
    O'Connor, Patrick
    Schottenfeld, Richard
    Fiellin, David
    Sullivan, Lynn
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S133 - S134
  • [36] HIV/AIDS Early Treatment May Have Cured Infant of HIV Infection
    Cohen, Jon
    SCIENCE, 2013, 339 (6124) : 1134 - 1134
  • [37] Buprenorphine for the treatment of depression?
    Balon, R.
    ACTA PSYCHIATRICA SCANDINAVICA, 2016, 134 (01) : 85 - 86
  • [38] Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058
    Metzger, David S.
    Donnell, Deborah
    Celentano, David D.
    Jackson, J. Brooks
    Shao, Yiming
    Aramrattana, Apinun
    Wei, Liu
    Fu, Liping
    Ma, Jun
    Lucas, Gregory M.
    Chawarski, Marek
    Ruan, Yuhua
    Richardson, Paul
    Shin, Katherine
    Chen, Ray Y.
    Sugarman, Jeremy
    Dye, Bonnie J.
    Rose, Scott M.
    Beauchamp, Geetha
    Burns, David N.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (05) : 554 - 561
  • [39] The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients
    Edelman, E. Jennifer
    Chantarat, Tongtan
    Caffrey, Sarah
    Chaudhry, Amina
    O'Connor, Patrick G.
    Weiss, Linda
    Fiellin, David A.
    Fiellin, Lynn E.
    DRUG AND ALCOHOL DEPENDENCE, 2014, 139 : 79 - 85
  • [40] Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics
    Korthuis, P. Todd
    Tozzi, Mary Jo
    Nandi, Vijay
    Fiellin, David A.
    Weiss, Linda
    Egan, James E.
    Botsko, Michael
    Acosta, Angela
    Gourevitch, Marc N.
    Hersh, David
    Hsu, Jeffrey
    Boverman, Joshua
    Altice, Frederick L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 : S39 - S45
12345